Liver Disease Diagnostics Market
Liver Disease Diagnostics Market Forecasts to 2030 - Global Analysis By Disease Type (Viral Hepatitis, Alcoholic Liver Disease, Non-alcoholic Fatty Liver Disease (NAFLD), Liver Cancer and Other Disease Types), Technique (Endoscopy, Biopsy, Imaging Techniques, Laboratory Tests and Other Techniques), End User (Hospitals, Laboratories, Research Institutes and Other End Users) and by Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $40.32 BN |
|
Projected Year Value (2030) |
US $69.54 BN |
|
CAGR (2023 - 2030) |
8.1% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Liver Disease Diagnostics Market is accounted for $40.32 billion in 2023 and is expected to reach $69.54 billion by 2030 growing at a CAGR of 8.1% during the forecast period. Diagnostics for liver diseases are essential for determining and treating a wide range of liver-related conditions. These diagnostics include a variety of procedures and imaging methods designed to evaluate the liver's health, identify anomalies, and identify the underlying causes of liver diseases. Moreover, blood tests to measure liver enzyme levels, such as alanine transaminase (ALT) and aspartate transaminase (AST), as well as tests to assess the presence of particular antibodies or viral markers, are commonly used diagnostic tools.
According to report of World Health Organization (WHO) published on June 2022, globally, an estimated 58 million people have chronic hepatitis C virus infection, with about 1.5 million new infections occurring per year.
Market Dynamics:
Driver:
Growing consciousness and screening initiatives
Liver disease diagnostics are in high demand due to growing public awareness of the seriousness of liver diseases, which has been fueled by campaigns from non-profits and healthcare groups. Additionally, early-stage diagnoses are increasing as a result of proactive screening programs, which typically target high-risk populations such as those with a history of substance abuse or particular demographics predisposed to liver disorders. In addition to lessening the strain on healthcare systems, this increased focus and awareness of preventive healthcare also give people the power to take control of their liver health through routine screenings.
Restraint:
Exorbitant expense of advanced diagnosis
A major barrier is the expense of cutting-edge liver disease diagnostics, which include sophisticated imaging methods and molecular testing. The total cost is influenced by a high initial investment, ongoing maintenance expenses, and the requirement for specialized training. Furthermore, this financial obstacle prevents these diagnostics from being widely used and made accessible to patients and healthcare organizations alike.
Opportunity:
Developments in customized medicine
There is a large opportunity for the liver disease diagnostics market due to the changing face of personalized medicine. Liver disease diagnosis and treatment can be made more accurate by customizing diagnostic strategies based on a person's genetic composition, lifestyle choices, and unique disease features. Moreover, the creation of targeted diagnostic tools is made possible by developments in genomics and molecular profiling, which open the door to more efficient and customized patient care.
Threat:
Issues with compliance and regulatory difficulties
The market for liver disease diagnostics is threatened by stricter and more dynamic regulatory environments. Companies face difficulties in terms of time, resources, and possible delays in product launches when they must follow compliance requirements, secure required approvals, and navigate complex regulatory processes. However, for market participants, non-compliance poses a serious risk of legal problems, market withdrawals, or restrictions.
Covid-19 Impact:
The market for liver disease diagnostics has been significantly impacted by the COVID-19 pandemic. The pandemic's worldwide disruption, which included lockdowns, overburdened healthcare systems, and the redirection of resources to fight the virus, temporarily, reduced the number of elective surgeries and routine medical visits, which had an impact on the demand for diagnostic services as a whole. Additionally, market participants faced difficulties due to delays in R&D projects, interruptions in the supply chain, and changes in healthcare priorities. Positively, the pandemic accelerated the adoption of tele-health and remote monitoring solutions by highlighting the significance of strong diagnostic capabilities.
The Non-alcoholic Fatty Liver Disease (NAFLD) segment is expected to be the largest during the forecast period
The non-alcoholic fatty liver disease (NAFLD) segment is anticipated to hold the largest share. Since obesity and metabolic syndrome are becoming more common, non-alcoholic fatty liver disease (NAFLD) has emerged as a major global cause of chronic liver disease. Furthermore, the rising prevalence of NAFLD, which can vary from mild hepatic steatosis to more serious illnesses like non-alcoholic steatohepatitis (NASH), is what drives the segment's dominance. Because of this, there has been a noticeable increase in the need for liver disease diagnostics, such as cutting-edge imaging methods and blood tests for precise NAFLD diagnosis and staging.
The Research Institutes segment is expected to have the highest CAGR during the forecast period
The segment with the highest CAGR during the estimation period is research institutes. Research institutes are essential for fostering innovation and technical progress in the development of diagnostic instruments and procedures. The robust growth of this segment can be attributed to the growing emphasis on translational research, biomarker discovery, and the development of innovative diagnostic technologies. Moreover, research institutes conduct clinical studies, validate diagnostic assays, and lead the way in developing novel diagnostic techniques in partnership with diagnostic companies and healthcare providers. Government grants and funding, along with the increased volume of research activity, are driving the Research Institutes sector forward.
Region with largest share:
North America is expected to hold the largest market share. A strong regulatory environment that encourages innovation, high healthcare spending, technological advancements, and a well-established healthcare infrastructure are some of the reasons for the region's dominance. Additionally, North America holds a dominant position in the liver disease diagnostics market due in part to the existence of important market players, research institutions, and a proactive approach towards adopting advanced diagnostic technologies.
Region with highest CAGR:
The healthcare diagnostics market is expected to grow at the highest CAGR in the Asia-Pacific region. The region's expanding population, the rising frequency of chronic diseases, the increased public awareness of early disease detection, and the significant investments made in healthcare infrastructure are all contributing factors to this. The rapid growth is mostly being driven by middle-class population expansion, government initiatives to increase healthcare accessibility, and technological advancements in countries like China and India. Furthermore, the Asia-Pacific region is well-positioned for strong growth in the healthcare diagnostics industry due to its dynamic nature and emphasis on implementing cutting-edge diagnostic solutions.
Key players in the market
Some of the key players in Liver Disease Diagnostics market include Abbott Laboratories, Horiba Medical, F. Hoffmann-La Roche Ltd., Cosara Diagnostics Pvt Ltd, Laboratory Corporation of America Holdings, Bio-Rad Laboratories Inc., Meril Life Sciences Pvt. Ltd., Fujifilm Corporation, PerkinElmer, Biosino Bio-Technology and Science Inc, Quest Diagnostics Incorporated, Trivitron Healthcare, Boston Scientific Corporation, Qiagen N.V, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc and Randox Laboratories Ltd.
Key Developments:
In December 2023, F. Hoffmann-La Roche Ltd. announced today the entry into a definitive merger agreement to acquire Carmot Therapeutics, Inc. (“Carmot”), a privately owned US company based in Berkeley, California. Carmot’s R&D portfolio includes clinical stage subcutaneous and oral incretins with best-in-class potential to treat obesity in patients with and without diabetes, as well as a number of preclinical programs.
In September 2023, Abbott has entered a definitive agreement for the acquisition of Bigfoot Biomedical, which develops smart insulin management systems for individuals with diabetes. Together, the companies have worked on connected diabetes solutions since 2017. Developed by Bigfoot Biomedical, Bigfoot Unity is a smart insulin management system. It features connected insulin pen caps that use integrated continuous glucose monitoring (iCGM) data and healthcare provider instructions.
In August 2022, HORIBA, one of the global leaders in a wide range of medical diagnostic equipment, and SigTuple, a medtech company that develops AI-powered digital microscopy solutions, announced today a partnership to accelerate adoption of SigTuple’s AI100 across the Indian subcontinent. HORIBA, a medical diagnostic company, and SigTuple, a MedTech company, on Monday, announced a partnership to accelerate the adoption of SigTuple’s AI100 across the Indian subcontinent.
Disease Types Covered:
• Viral Hepatitis
• Alcoholic Liver Disease
• Non-alcoholic Fatty Liver Disease (NAFLD)
• Liver Cancer
• Other Disease Types
Techniques Covered:
• Endoscopy
• Biopsy
• Imaging Techniques
• Laboratory Tests
• Other Techniques
End Users Covered:
• Hospitals
• Laboratories
• Research Institutes
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Liver Disease Diagnostics Market, By Disease Type
5.1 Introduction
5.2 Viral Hepatitis
5.3 Alcoholic Liver Disease
5.4 Non-alcoholic Fatty Liver Disease (NAFLD)
5.5 Liver Cancer
5.6 Other Disease Types
6 Global Liver Disease Diagnostics Market, By Technique
6.1 Introduction
6.2 Endoscopy
6.3 Biopsy
6.4 Imaging Techniques
6.4.1 Ultrasound
6.4.2 MRI
6.4.3 CT Scan
6.5 Laboratory Tests
6.5.1 Blood Tests
6.5.2 Liver Function Tests
6.5.3 Genetic Tests
6.6 Other Techniques
7 Global Liver Disease Diagnostics Market, By End User
7.1 Introduction
7.2 Hospitals
7.3 Laboratories
7.4 Research Institutes
7.5 Other End Users
8 Global Liver Disease Diagnostics Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Abbott Laboratories
10.2 Horiba Medical
10.3 F. Hoffmann-La Roche Ltd.
10.4 Cosara Diagnostics Pvt Ltd
10.5 Laboratory Corporation of America Holdings
10.6 Bio-Rad Laboratories Inc.
10.7 Meril Life Sciences Pvt. Ltd.
10.8 Fujifilm Corporation
10.9 PerkinElmer
10.10 Biosino Bio-Technology and Science Inc
10.11 Quest Diagnostics Incorporated
10.12 Trivitron Healthcare
10.13 Boston Scientific Corporation
10.14 Qiagen N.V
10.15 Siemens Healthcare GmbH
10.16 Thermo Fisher Scientific Inc
10.17 Randox Laboratories Ltd.
List of Tables
1 Global Liver Disease Diagnostics Market Outlook, By Region (2021-2030) ($MN)
2 Global Liver Disease Diagnostics Market Outlook, By Disease Type (2021-2030) ($MN)
3 Global Liver Disease Diagnostics Market Outlook, By Viral Hepatitis (2021-2030) ($MN)
4 Global Liver Disease Diagnostics Market Outlook, By Alcoholic Liver Disease (2021-2030) ($MN)
5 Global Liver Disease Diagnostics Market Outlook, By Non-alcoholic Fatty Liver Disease (NAFLD) (2021-2030) ($MN)
6 Global Liver Disease Diagnostics Market Outlook, By Liver Cancer (2021-2030) ($MN)
7 Global Liver Disease Diagnostics Market Outlook, By Other Disease Types (2021-2030) ($MN)
8 Global Liver Disease Diagnostics Market Outlook, By Technique (2021-2030) ($MN)
9 Global Liver Disease Diagnostics Market Outlook, By Endoscopy (2021-2030) ($MN)
10 Global Liver Disease Diagnostics Market Outlook, By Biopsy (2021-2030) ($MN)
11 Global Liver Disease Diagnostics Market Outlook, By Imaging Techniques (2021-2030) ($MN)
12 Global Liver Disease Diagnostics Market Outlook, By Ultrasound (2021-2030) ($MN)
13 Global Liver Disease Diagnostics Market Outlook, By MRI (2021-2030) ($MN)
14 Global Liver Disease Diagnostics Market Outlook, By CT Scan (2021-2030) ($MN)
15 Global Liver Disease Diagnostics Market Outlook, By Laboratory Tests (2021-2030) ($MN)
16 Global Liver Disease Diagnostics Market Outlook, By Blood Tests (2021-2030) ($MN)
17 Global Liver Disease Diagnostics Market Outlook, By Liver Function Tests (2021-2030) ($MN)
18 Global Liver Disease Diagnostics Market Outlook, By Genetic Tests (2021-2030) ($MN)
19 Global Liver Disease Diagnostics Market Outlook, By Other Techniques (2021-2030) ($MN)
20 Global Liver Disease Diagnostics Market Outlook, By End User (2021-2030) ($MN)
21 Global Liver Disease Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
22 Global Liver Disease Diagnostics Market Outlook, By Laboratories (2021-2030) ($MN)
23 Global Liver Disease Diagnostics Market Outlook, By Research Institutes (2021-2030) ($MN)
24 Global Liver Disease Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
25 North America Liver Disease Diagnostics Market Outlook, By Country (2021-2030) ($MN)
26 North America Liver Disease Diagnostics Market Outlook, By Disease Type (2021-2030) ($MN)
27 North America Liver Disease Diagnostics Market Outlook, By Viral Hepatitis (2021-2030) ($MN)
28 North America Liver Disease Diagnostics Market Outlook, By Alcoholic Liver Disease (2021-2030) ($MN)
29 North America Liver Disease Diagnostics Market Outlook, By Non-alcoholic Fatty Liver Disease (NAFLD) (2021-2030) ($MN)
30 North America Liver Disease Diagnostics Market Outlook, By Liver Cancer (2021-2030) ($MN)
31 North America Liver Disease Diagnostics Market Outlook, By Other Disease Types (2021-2030) ($MN)
32 North America Liver Disease Diagnostics Market Outlook, By Technique (2021-2030) ($MN)
33 North America Liver Disease Diagnostics Market Outlook, By Endoscopy (2021-2030) ($MN)
34 North America Liver Disease Diagnostics Market Outlook, By Biopsy (2021-2030) ($MN)
35 North America Liver Disease Diagnostics Market Outlook, By Imaging Techniques (2021-2030) ($MN)
36 North America Liver Disease Diagnostics Market Outlook, By Ultrasound (2021-2030) ($MN)
37 North America Liver Disease Diagnostics Market Outlook, By MRI (2021-2030) ($MN)
38 North America Liver Disease Diagnostics Market Outlook, By CT Scan (2021-2030) ($MN)
39 North America Liver Disease Diagnostics Market Outlook, By Laboratory Tests (2021-2030) ($MN)
40 North America Liver Disease Diagnostics Market Outlook, By Blood Tests (2021-2030) ($MN)
41 North America Liver Disease Diagnostics Market Outlook, By Liver Function Tests (2021-2030) ($MN)
42 North America Liver Disease Diagnostics Market Outlook, By Genetic Tests (2021-2030) ($MN)
43 North America Liver Disease Diagnostics Market Outlook, By Other Techniques (2021-2030) ($MN)
44 North America Liver Disease Diagnostics Market Outlook, By End User (2021-2030) ($MN)
45 North America Liver Disease Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
46 North America Liver Disease Diagnostics Market Outlook, By Laboratories (2021-2030) ($MN)
47 North America Liver Disease Diagnostics Market Outlook, By Research Institutes (2021-2030) ($MN)
48 North America Liver Disease Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
49 Europe Liver Disease Diagnostics Market Outlook, By Country (2021-2030) ($MN)
50 Europe Liver Disease Diagnostics Market Outlook, By Disease Type (2021-2030) ($MN)
51 Europe Liver Disease Diagnostics Market Outlook, By Viral Hepatitis (2021-2030) ($MN)
52 Europe Liver Disease Diagnostics Market Outlook, By Alcoholic Liver Disease (2021-2030) ($MN)
53 Europe Liver Disease Diagnostics Market Outlook, By Non-alcoholic Fatty Liver Disease (NAFLD) (2021-2030) ($MN)
54 Europe Liver Disease Diagnostics Market Outlook, By Liver Cancer (2021-2030) ($MN)
55 Europe Liver Disease Diagnostics Market Outlook, By Other Disease Types (2021-2030) ($MN)
56 Europe Liver Disease Diagnostics Market Outlook, By Technique (2021-2030) ($MN)
57 Europe Liver Disease Diagnostics Market Outlook, By Endoscopy (2021-2030) ($MN)
58 Europe Liver Disease Diagnostics Market Outlook, By Biopsy (2021-2030) ($MN)
59 Europe Liver Disease Diagnostics Market Outlook, By Imaging Techniques (2021-2030) ($MN)
60 Europe Liver Disease Diagnostics Market Outlook, By Ultrasound (2021-2030) ($MN)
61 Europe Liver Disease Diagnostics Market Outlook, By MRI (2021-2030) ($MN)
62 Europe Liver Disease Diagnostics Market Outlook, By CT Scan (2021-2030) ($MN)
63 Europe Liver Disease Diagnostics Market Outlook, By Laboratory Tests (2021-2030) ($MN)
64 Europe Liver Disease Diagnostics Market Outlook, By Blood Tests (2021-2030) ($MN)
65 Europe Liver Disease Diagnostics Market Outlook, By Liver Function Tests (2021-2030) ($MN)
66 Europe Liver Disease Diagnostics Market Outlook, By Genetic Tests (2021-2030) ($MN)
67 Europe Liver Disease Diagnostics Market Outlook, By Other Techniques (2021-2030) ($MN)
68 Europe Liver Disease Diagnostics Market Outlook, By End User (2021-2030) ($MN)
69 Europe Liver Disease Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
70 Europe Liver Disease Diagnostics Market Outlook, By Laboratories (2021-2030) ($MN)
71 Europe Liver Disease Diagnostics Market Outlook, By Research Institutes (2021-2030) ($MN)
72 Europe Liver Disease Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
73 Asia Pacific Liver Disease Diagnostics Market Outlook, By Country (2021-2030) ($MN)
74 Asia Pacific Liver Disease Diagnostics Market Outlook, By Disease Type (2021-2030) ($MN)
75 Asia Pacific Liver Disease Diagnostics Market Outlook, By Viral Hepatitis (2021-2030) ($MN)
76 Asia Pacific Liver Disease Diagnostics Market Outlook, By Alcoholic Liver Disease (2021-2030) ($MN)
77 Asia Pacific Liver Disease Diagnostics Market Outlook, By Non-alcoholic Fatty Liver Disease (NAFLD) (2021-2030) ($MN)
78 Asia Pacific Liver Disease Diagnostics Market Outlook, By Liver Cancer (2021-2030) ($MN)
79 Asia Pacific Liver Disease Diagnostics Market Outlook, By Other Disease Types (2021-2030) ($MN)
80 Asia Pacific Liver Disease Diagnostics Market Outlook, By Technique (2021-2030) ($MN)
81 Asia Pacific Liver Disease Diagnostics Market Outlook, By Endoscopy (2021-2030) ($MN)
82 Asia Pacific Liver Disease Diagnostics Market Outlook, By Biopsy (2021-2030) ($MN)
83 Asia Pacific Liver Disease Diagnostics Market Outlook, By Imaging Techniques (2021-2030) ($MN)
84 Asia Pacific Liver Disease Diagnostics Market Outlook, By Ultrasound (2021-2030) ($MN)
85 Asia Pacific Liver Disease Diagnostics Market Outlook, By MRI (2021-2030) ($MN)
86 Asia Pacific Liver Disease Diagnostics Market Outlook, By CT Scan (2021-2030) ($MN)
87 Asia Pacific Liver Disease Diagnostics Market Outlook, By Laboratory Tests (2021-2030) ($MN)
88 Asia Pacific Liver Disease Diagnostics Market Outlook, By Blood Tests (2021-2030) ($MN)
89 Asia Pacific Liver Disease Diagnostics Market Outlook, By Liver Function Tests (2021-2030) ($MN)
90 Asia Pacific Liver Disease Diagnostics Market Outlook, By Genetic Tests (2021-2030) ($MN)
91 Asia Pacific Liver Disease Diagnostics Market Outlook, By Other Techniques (2021-2030) ($MN)
92 Asia Pacific Liver Disease Diagnostics Market Outlook, By End User (2021-2030) ($MN)
93 Asia Pacific Liver Disease Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
94 Asia Pacific Liver Disease Diagnostics Market Outlook, By Laboratories (2021-2030) ($MN)
95 Asia Pacific Liver Disease Diagnostics Market Outlook, By Research Institutes (2021-2030) ($MN)
96 Asia Pacific Liver Disease Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
97 South America Liver Disease Diagnostics Market Outlook, By Country (2021-2030) ($MN)
98 South America Liver Disease Diagnostics Market Outlook, By Disease Type (2021-2030) ($MN)
99 South America Liver Disease Diagnostics Market Outlook, By Viral Hepatitis (2021-2030) ($MN)
100 South America Liver Disease Diagnostics Market Outlook, By Alcoholic Liver Disease (2021-2030) ($MN)
101 South America Liver Disease Diagnostics Market Outlook, By Non-alcoholic Fatty Liver Disease (NAFLD) (2021-2030) ($MN)
102 South America Liver Disease Diagnostics Market Outlook, By Liver Cancer (2021-2030) ($MN)
103 South America Liver Disease Diagnostics Market Outlook, By Other Disease Types (2021-2030) ($MN)
104 South America Liver Disease Diagnostics Market Outlook, By Technique (2021-2030) ($MN)
105 South America Liver Disease Diagnostics Market Outlook, By Endoscopy (2021-2030) ($MN)
106 South America Liver Disease Diagnostics Market Outlook, By Biopsy (2021-2030) ($MN)
107 South America Liver Disease Diagnostics Market Outlook, By Imaging Techniques (2021-2030) ($MN)
108 South America Liver Disease Diagnostics Market Outlook, By Ultrasound (2021-2030) ($MN)
109 South America Liver Disease Diagnostics Market Outlook, By MRI (2021-2030) ($MN)
110 South America Liver Disease Diagnostics Market Outlook, By CT Scan (2021-2030) ($MN)
111 South America Liver Disease Diagnostics Market Outlook, By Laboratory Tests (2021-2030) ($MN)
112 South America Liver Disease Diagnostics Market Outlook, By Blood Tests (2021-2030) ($MN)
113 South America Liver Disease Diagnostics Market Outlook, By Liver Function Tests (2021-2030) ($MN)
114 South America Liver Disease Diagnostics Market Outlook, By Genetic Tests (2021-2030) ($MN)
115 South America Liver Disease Diagnostics Market Outlook, By Other Techniques (2021-2030) ($MN)
116 South America Liver Disease Diagnostics Market Outlook, By End User (2021-2030) ($MN)
117 South America Liver Disease Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
118 South America Liver Disease Diagnostics Market Outlook, By Laboratories (2021-2030) ($MN)
119 South America Liver Disease Diagnostics Market Outlook, By Research Institutes (2021-2030) ($MN)
120 South America Liver Disease Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
121 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Country (2021-2030) ($MN)
122 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Disease Type (2021-2030) ($MN)
123 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Viral Hepatitis (2021-2030) ($MN)
124 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Alcoholic Liver Disease (2021-2030) ($MN)
125 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Non-alcoholic Fatty Liver Disease (NAFLD) (2021-2030) ($MN)
126 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Liver Cancer (2021-2030) ($MN)
127 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Other Disease Types (2021-2030) ($MN)
128 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Technique (2021-2030) ($MN)
129 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Endoscopy (2021-2030) ($MN)
130 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Biopsy (2021-2030) ($MN)
131 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Imaging Techniques (2021-2030) ($MN)
132 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Ultrasound (2021-2030) ($MN)
133 Middle East & Africa Liver Disease Diagnostics Market Outlook, By MRI (2021-2030) ($MN)
134 Middle East & Africa Liver Disease Diagnostics Market Outlook, By CT Scan (2021-2030) ($MN)
135 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Laboratory Tests (2021-2030) ($MN)
136 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Blood Tests (2021-2030) ($MN)
137 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Liver Function Tests (2021-2030) ($MN)
138 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Genetic Tests (2021-2030) ($MN)
139 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Other Techniques (2021-2030) ($MN)
140 Middle East & Africa Liver Disease Diagnostics Market Outlook, By End User (2021-2030) ($MN)
141 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
142 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Laboratories (2021-2030) ($MN)
143 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Research Institutes (2021-2030) ($MN)
144 Middle East & Africa Liver Disease Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
